首页> 美国卫生研究院文献>Clinical Epidemiology >Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants

【2h】

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants

机译：心房颤动患者的中风发病率和死亡用直接口服抗凝血剂新治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The objectives were to analyse the determinants of stroke incidence and mortality as a competing event in AF patients newly treated with DOAC and to assess the impact of non-adherence to DOAC treatment.

机译：目的是分析中风发病率和死亡率的决定因素，作为AFAC患者的竞争事件，并评估不遵守Doac治疗的影响。

著录项

期刊名称 Clinical Epidemiology
作者
Amélie Gabet; Edouard Chatignoux; Clémence Grave; Alexandre Vallée; Philippe Tuppin; Yannick Béjot; Valérie Olié;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类病毒传染病 ;
关键词
atrial fibrillation; stroke; death; adherence; direct oral anticoagulants;

机译：心房颤动;中风;死亡;依恋;直接口服抗凝剂;

相似文献

外文文献
中文文献
专利

1. Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy [J] . Nagao Tomoyuki, Suzuki Hitomi, Matsunaga Syun, Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . 2019 ,第4期

机译：脉细胞抗凝治疗对接受直接口服抗凝剂患者心房颤动消融后无声脑卒中发生率的影响：不间断对一剂策略中断的影响
2. META-ANALYSIS OF CAUSES OF DEATH IN PATIENTS RECEIVING DIRECT ORAL ANTICOAGULANTS OR WARFARIN FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION [J] . Gomez Outes A., Lagunar J., Terleira A. I, Basic & clinical pharmacology & toxicology. . 2016 ,第Suppla1期

机译：接受直接口服口服抗凝剂或华法林预防心房纤颤和系统性中风的患者死亡原因的meta分析
3. Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants [J] . Doi Atsushi, Takagi Masahiko, Kakihara Jun, Heart and vessels: An international journal . 2017 ,第10期

机译：直接口服抗凝剂治疗患者中心房颤动后静音脑血栓栓塞病变的发病率和预测因子
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants [O] . Christine L. Baker, Amol D. Dhamane, Jigar Rajpura, 2019

机译：不同直接口服抗凝药治疗老年非瓣膜性房颤患者改用另一种口服抗凝药和停药
7. Editorial comment on ‘A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation’. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants? [O] . Shinichi Goto, Shinya Goto 2015

机译：编辑评论'一种小型方法间接比较益处：心房颤动患者口服抗血栓性疗法的风险'。是对充足性颤动患者的患者的当前剂量调整的抗凝，足以与新开发的非维生素K口腔抗凝剂进行比较吗？

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants

摘要

著录项

相似文献

相关主题

期刊订阅